The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials

BACKGROUND: HIV-associated lipodystrophy syndrome (HALS) is characterized by insulin resistance, abnormal lipid metabolism and redistribution of body fat. To date, there has been no quantitative summary of the effects of insulin sensitizing-agents for the treatment of this challenging problem. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheth, Siddharth H, Larson, Robin J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906460/
https://www.ncbi.nlm.nih.gov/pubmed/20573187
http://dx.doi.org/10.1186/1471-2334-10-183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906460/
https://www.ncbi.nlm.nih.gov/pubmed/20573187
http://dx.doi.org/10.1186/1471-2334-10-183

Ejemplares similares